191 related articles for article (PubMed ID: 31069142)
1. WISP1 is associated to advanced disease, EMT and an inflamed tumor microenvironment in multiple solid tumors.
Gaudreau PO; Clairefond S; Class CA; Boulay PL; Chrobak P; Allard B; Azzi F; Pommey S; Do KA; Saad F; Trudel D; Young M; Stagg J
Oncoimmunology; 2019; 8(5):e1581545. PubMed ID: 31069142
[No Abstract] [Full Text] [Related]
2. WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial-mesenchymal transition.
Deng W; Fernandez A; McLaughlin SL; Klinke DJ
J Biol Chem; 2019 Apr; 294(14):5261-5280. PubMed ID: 30723155
[TBL] [Abstract][Full Text] [Related]
3. WISP1 aggravates cell metastatic potential by abrogating TGF-
Song D; Wang L; Su K; Wu H; Li J
Exp Biol Med (Maywood); 2021 Jun; 246(11):1244-1252. PubMed ID: 33593111
[TBL] [Abstract][Full Text] [Related]
4. High Expression of PDLIM2 Predicts a Poor Prognosis in Prostate Cancer and Is Correlated with Epithelial-Mesenchymal Transition and Immune Cell Infiltration.
Piao S; Zheng L; Zheng H; Zhou M; Feng Q; Zhou S; Ke M; Yang H; Wang X
J Immunol Res; 2022; 2022():2922832. PubMed ID: 35707002
[TBL] [Abstract][Full Text] [Related]
5. Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy.
Thompson JC; Hwang WT; Davis C; Deshpande C; Jeffries S; Rajpurohit Y; Krishna V; Smirnov D; Verona R; Lorenzi MV; Langer CJ; Albelda SM
Lung Cancer; 2020 Jan; 139():1-8. PubMed ID: 31683225
[TBL] [Abstract][Full Text] [Related]
6. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
7. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
8. WISP1 silencing confers protection against epithelial-mesenchymal transition of renal tubular epithelial cells in rats via inactivation of the wnt/β-catenin signaling pathway in uremia.
Chen YZ; Sun DQ; Zheng Y; Zheng GK; Chen RQ; Lin M; Huang LF; Huang C; Song D; Wu BQ
J Cell Physiol; 2019 Jun; 234(6):9673-9686. PubMed ID: 30556898
[TBL] [Abstract][Full Text] [Related]
9. Optimal CCN4 Immunofluorescence for Tissue Microarray.
Gaudreau PO; Cousineau I; Stagg J
Methods Mol Biol; 2023; 2582():13-21. PubMed ID: 36370340
[TBL] [Abstract][Full Text] [Related]
10. WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer.
Chiang KC; Yeh CN; Chung LC; Feng TH; Sun CC; Chen MF; Jan YY; Yeh TS; Chen SC; Juang HH
Sci Rep; 2015 Mar; 5():8686. PubMed ID: 25732125
[TBL] [Abstract][Full Text] [Related]
11. hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC.
Trono P; Tocci A; Palermo B; Di Carlo A; D'Ambrosio L; D'Andrea D; Di Modugno F; De Nicola F; Goeman F; Corleone G; Warren S; Paolini F; Panetta M; Sperduti I; Baldari S; Visca P; Carpano S; Cappuzzo F; Russo V; Tripodo C; Zucali P; Gregorc V; Marchesi F; Nistico P
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37612043
[TBL] [Abstract][Full Text] [Related]
12. Identifies microtubule-binding protein
Wang W; Zhang J; Wang Y; Xu Y; Zhang S
Comput Struct Biotechnol J; 2022; 20():3322-3335. PubMed ID: 35832625
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma.
Lou Y; Diao L; Cuentas ER; Denning WL; Chen L; Fan YH; Byers LA; Wang J; Papadimitrakopoulou VA; Behrens C; Rodriguez JC; Hwu P; Wistuba II; Heymach JV; Gibbons DL
Clin Cancer Res; 2016 Jul; 22(14):3630-42. PubMed ID: 26851185
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 Expression in Colorectal Adenocarcinoma Is Associated With the Tumor Immune Microenvironment and Epithelial-Mesenchymal Transition.
Secinti IE; Ozgur T; Dede I
Am J Clin Pathol; 2022 Oct; 158(4):506-515. PubMed ID: 35938631
[TBL] [Abstract][Full Text] [Related]
15. WISP1 Predicts Clinical Prognosis and Is Associated With Tumor Purity, Immunocyte Infiltration, and Macrophage M2 Polarization in Pan-Cancer.
Liao X; Bu Y; Xu Z; Jia F; Chang F; Liang J; Jia Q; Lv Y
Front Genet; 2020; 11():502. PubMed ID: 32523603
[TBL] [Abstract][Full Text] [Related]
16. WNT1 Inducible Signaling Pathway Protein 1 Is a Stroma-Specific Secreting Protein Inducing a Fibroblast Contraction and Carcinoma Cell Growth in the Human Prostate.
Chang KS; Chen ST; Sung HC; Hsu SY; Lin WY; Hou CP; Lin YH; Feng TH; Tsui KH; Juang HH
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232736
[TBL] [Abstract][Full Text] [Related]
17. Identification of a cytokine-dominated immunosuppressive class in squamous cell lung carcinoma with implications for immunotherapy resistance.
Yang M; Lin C; Wang Y; Chen K; Zhang H; Li W
Genome Med; 2022 Jul; 14(1):72. PubMed ID: 35799269
[TBL] [Abstract][Full Text] [Related]
18. Effect of WISP1 on paraquat-induced EMT.
Liu J; Lv S; Ma W; Yang D; Zhang X
Toxicol In Vitro; 2023 Dec; 93():105693. PubMed ID: 37689312
[TBL] [Abstract][Full Text] [Related]
19. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response.
Tian X; Xu WH; Xu FJ; Li H; Anwaier A; Wang HK; Wan FN; Zhu Y; Cao DL; Zhu YP; Shi GH; Qu YY; Zhang HL; Ye DW
Ann Med; 2022 Dec; 54(1):211-226. PubMed ID: 35037540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
